{{Rsnum
|rsid=2797512
|Gene=ERMP1
|Chromosome=9
|position=5807444
|Orientation=plus
|GMAF=0.04913
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
|Gene_s=ERMP1
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 100.0 | 0.0 | 0.0
| HCB | 100.0 | 0.0 | 0.0
| JPT | 100.0 | 0.0 | 0.0
| YRI | 61.2 | 33.3 | 5.4
| ASW | 70.2 | 29.8 | 0.0
| CHB | 100.0 | 0.0 | 0.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 59.1 | 38.2 | 2.7
| MEX | 91.4 | 8.6 | 0.0
| MKK | 54.5 | 39.1 | 6.4
| TSI | 99.0 | 1.0 | 0.0
| HapMapRevision=28
}}
{{PMID Auto
|PMID=19624767
|Title=Influence of inducible nitric oxide synthase polymorphisms in Japanese patients with non-alcoholic fatty liver disease
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}